Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | SVP, Cont & Chief Acct Officer | April 01, 2013 | April 03, 2013 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2013 · Filed April 03, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 28,489 |
Reported balance
After 2013-04-01 transaction · row 1
1 source rowRow 1 · 2013-04-01 · Grant · Acquired 4,585 · Balance 28,489 F1: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. |
| Common StockSEC Table I · non-derivative | Direct | 17,845.1281 |
Reported balance
After 2013-04-01 transaction · row 2
1 source rowRow 2 · 2013-04-01 · Tax withholding · Disposed 445 · Balance 17,845.1281 F2: Surrender of shares in payment of withholding taxes due. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.53 · Expires 2020-04-01 | Direct | 19,670 |
Reported balance
After 2013-04-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2013-04-01 · Grant · Acquired 19,670 · Balance 19,670 F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $34.42 · Expires 2014-04-02 | Direct | 9,451 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 9,451 F4: Option became exercisable in three equal annual installments, commencing 4/1/2008. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $41.17 · Expires 2015-04-01 | Direct | 10,811 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,811 F5: Option became exercisable in three equal annual installments, commencing 4/1/2009. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $28.10 · Expires 2016-04-01 | Direct | 16,060 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 16,060 F6: Option became exercisable in three equal annual installments, commencing 4/1/2010. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $36.23 · Expires 2017-04-01 | Direct | 34,423 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 34,423 F7: Option became exercisable in three equal annual installments, commencing 4/1/2011. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $34.96 · Expires 2018-04-01 | Direct | 34,833 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 34,833 F8: Option became exercisable in four equal annual installments, commencing 4/1/2012. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $32.98 · Expires 2020-01-04 | Direct | 15,170 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 15,170 F9: Option became exercisable in three equal annual installments, commencing 1/4/2013. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $45.07 · Expires 2019-04-02 | Direct | 19,965 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 19,965 F10: Option became exercisable in four equal annual installments, commencing 4/2/2013. |
| Common Stock (pep)SEC Table I · non-derivative | Direct | 1,584.4198 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,584.4198 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018.
F2: Surrender of shares in payment of withholding taxes due.
F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2014.
F4: Option became exercisable in three equal annual installments, commencing 4/1/2008.
F5: Option became exercisable in three equal annual installments, commencing 4/1/2009.
F6: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F7: Option became exercisable in three equal annual installments, commencing 4/1/2011.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2012.
F9: Option became exercisable in three equal annual installments, commencing 1/4/2013.
F10: Option became exercisable in four equal annual installments, commencing 4/2/2013.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2013 Filed Apr 3, 2013 20:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 19,670 | $54.53 Strike: $54.53 | $1,072,605.10 |
DisclosureSEC source: 0001127602-13-013302 · form4.xml · derivative · entry 4 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,670 Underlying: Common Stock · 19,670 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 445 | $54.53 | $24,265.85 |
DisclosureSEC source: 0001127602-13-013302 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,845.1281 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,585 | $54.53 | $250,020.05 |
DisclosureSEC source: 0001127602-13-013302 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,489 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| February 19, 2013 Filed Feb 28, 2013 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,273 | $52.66 | $225,016.18 |
DisclosureSEC source: 0001127602-13-008496 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,239 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing February 19, 2014. Read SEC document |
| February 17, 2013 Filed Feb 19, 2013 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 249 | $51.12 | $12,728.88 |
DisclosureSEC source: 0001127602-13-006761 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,955.1281 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 15, 2013 Filed Feb 19, 2013 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 273 | $51.12 | $13,955.76 |
DisclosureSEC source: 0001127602-13-006761 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,439.1281 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2013 Filed Feb 11, 2013 21:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 269 | $51.19 | $13,770.11 |
DisclosureSEC source: 0001127602-13-005351 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,872.1281 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 19,965 | $45.07 Strike: $45.07 | $899,822.55 |
DisclosureSEC source: 0001127602-12-013323 · form4.xml · derivative · entry 4 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,965 Underlying: Common Stock · 19,965 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 247 | $45.07 | $11,132.29 |
DisclosureSEC source: 0001127602-12-013323 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,822.9237 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,993 | $45.07 | $225,034.51 |
DisclosureSEC source: 0001127602-12-013323 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,267 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on 4/2/2016. Read SEC document |
| April 02, 2012 Filed Jun 12, 2012 19:54 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,993 | $45.07 | $225,034.51 |
DisclosureSEC source: 0001127602-12-019906 · form4a.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,267 F1 · shares: The purpose of this Form 4/A is to correct the vesting schedule of the reporting person's restricted stock award, which was initially incorrectly reported due to a clerical error. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| February 18, 2012 Filed Feb 21, 2012 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 194 | $44.27 | $8,588.38 |
DisclosureSEC source: 0001127602-12-007094 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,309.9237 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 249 | $44.27 | $11,023.23 |
DisclosureSEC source: 0001127602-12-007094 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,503.9237 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 15, 2012 Filed Feb 17, 2012 21:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 273 | $43.53 | $11,883.69 |
DisclosureSEC source: 0001127602-12-006665 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392.9237 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 22:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,571 | $43.08 | $110,758.68 |
DisclosureSEC source: 0001127602-12-004955 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,825.9237 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 22:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 2,090 | $43.08 | $90,037.20 |
DisclosureSEC source: 0001127602-12-004955 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing February 7, 2013. Read SEC document |
| April 02, 2011 Filed Apr 5, 2011 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 295 | $34.96 | $10,313.20 |
DisclosureSEC source: 0001127602-11-012445 · form4.xml · nonDerivative · entry 3 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,610.05 F3 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 34,833 | $34.96 Strike: $34.96 | $1,217,761.68 |
DisclosureSEC source: 0001127602-11-012445 · form4.xml · derivative · entry 5 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,833 Underlying: Common Stock · 34,833 shares Expires 2018-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 9,297 | $34.96 | $325,023.12 |
DisclosureSEC source: 0001127602-11-012445 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,052 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments, 50% on 4/1/2014 and 50% on 4/1/2016. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,576 | $34.96 | $55,096.96 |
DisclosureSEC source: 0001127602-11-012445 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,905.05 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 18, 2011 Filed Feb 22, 2011 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 194 | $33.06 | $6,413.64 |
DisclosureSEC source: 0001127602-11-006759 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,757.3442 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2011 Filed Feb 22, 2011 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 273 | $32.76 | $8,943.48 |
DisclosureSEC source: 0001127602-11-006759 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,951.3442 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 15, 2011 Filed Feb 16, 2011 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 2,521 | $32.98 | $83,142.58 |
DisclosureSEC source: 0001127602-11-005820 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,973 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on three equal installments, commencing 2/15/2012. Read SEC document |
| February 12, 2011 Filed Feb 16, 2011 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 334 | $33.03 | $11,032.02 |
DisclosureSEC source: 0001127602-11-005820 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,199 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2010 Filed Sep 23, 2010 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 34,423 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-023732 · form4.xml · derivative · entry 4 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,423 Underlying: Common Stock · 34,423 shares Expires 2017-04-01 F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 01, 2010 Filed Sep 23, 2010 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-023732 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,878 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 4/1/2014. Read SEC document |
| February 18, 2010 Filed Feb 19, 2010 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005620 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,624 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2010 Filed Feb 19, 2010 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 2,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005620 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,367 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on three equal installments, commencing 2/17/2011. Read SEC document |
| February 16, 2010 Filed Feb 17, 2010 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005100 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 12, 2010 Filed Feb 17, 2010 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005100 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,301 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| January 04, 2010 Filed Jan 6, 2010 21:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 15,170 | $0.00 Strike: $32.98 | $0.00 |
DisclosureSEC source: 0001127602-10-000950 · form4.xml · derivative · entry 4 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,170 Underlying: Common Stock · 15,170 shares Expires 2020-01-04 F4 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 1/4/2013. Read SEC document |
| January 04, 2010 Filed Jan 6, 2010 21:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (pep) | 1,517 | $32.98 | $50,030.66 |
DisclosureSEC source: 0001127602-10-000950 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program under the 1997 Incentive Compensation Plan. Restrictions lapse on 1/4/2015. Read SEC document |
| January 04, 2010 Filed Jan 6, 2010 21:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 845 | $32.98 | $27,868.10 |
DisclosureSEC source: 0001127602-10-000950 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,270 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.